首页> 外文期刊>BMC Endocrine Disorders >Effectiveness of diabetes self-management education via a smartphone application in insulin treated type 2 diabetes patients – design of a randomised controlled trial (‘TRIGGER study’)
【24h】

Effectiveness of diabetes self-management education via a smartphone application in insulin treated type 2 diabetes patients – design of a randomised controlled trial (‘TRIGGER study’)

机译:通过智能手机应用程序对糖尿病治疗的2型糖尿病患者进行糖尿病自我管理教育的有效性–一项随机对照试验的设计(“ TRIGGER研究”)

获取原文
           

摘要

Health care providers aim to stimulate self-management in type 2 diabetes (T2DM) patients. However, they have a limited number of patient contacts to do this. With the growing number of T2DM patients, innovative and cost-effective interventions to promote self-management are needed. We aim to evaluate the effectiveness of diabetes self-management education via a smartphone app in T2DM patients on insulin therapy. Non-blinded two-arm multi-centre randomised controlled superiority trial with parallel-groups and equal randomisation (‘TRIGGER study’). Eligible patients are 40–70?years, on insulin therapy since at least 3 months, with HbA1c ?53?mmol/mol (?7%). In total 228 patients will be recruited. The intervention group (n?=?114) will receive diabetes self-management education via a smartphone app to trigger diabetes self-management: unidirectional text messages, free of charge, evidence and psychological theory based, with regard to dietary habits, physical activity, hypoglycaemia and glucose variability. Patients choose their preferred frequency (two to six times per week), topics (two or three additionally to hypoglycaemia, which is an obligatory topic), and duration (6 or 9 months). The control group (n?=?114) will receive care-as-usual. The primary study endpoint is the HbA1c level after a follow-up of 6 months. The percentage of patients who achieve an HbA1c level?≤?53?mmol/mol (≤7%) without hypoglycaemia (plasma glucose ?3.5?mmol/L (?63?mg/dL)) is a co-primary outcome. Secondary outcomes are body mass index, waist circumference, insulin dose, lipid profile, blood pressure, number of hypoglycaemic events, glycaemic variability, self-management (SDSCA), food habits (FFQ), physical activity (IPAQ), health status (EQ-5D-5?L, SF36), diabetes-dependent quality of life (ADDQoL), diabetes treatment satisfaction (DTSQ), satisfaction with the app, the cost-effectiveness of the intervention after 3 months, and sustainability of the intervention effect (3 months extra follow-up in intervention group to compare prolonged to discontinued use of the app). We will use the intention-to-treat principle to analyse data. Innovative solutions are needed to improve the (cost-) effectiveness of self-management for the increasing number of T2DM patients. This trial will provide evidence on the effectiveness of a newly developed smartphone app, designed to trigger diabetes self-management. Dutch Trial Register NTR5515 , registration date: 18 November 2015 (prospectively registered).
机译:卫生保健提供者旨在刺激2型糖尿病(T2DM)患者的自我管理。但是,这样做的病人联系数量有限。随着T2DM患者人数的增加,需要采取创新且具有成本效益的干预措施来促进自我管理。我们旨在通过智能手机应用评估糖尿病自我管理教育在接受胰岛素治疗的T2DM患者中的有效性。两组均等且随机分组的无盲法两臂多中心随机对照优势试验(“ TRIGGER研究”)。符合条件的患者至少在3个月后接受胰岛素治疗40-70?年,HbA1c>?53?mmol / mol(>?7%)。总共将招募228名患者。干预组(n = 114)将通过智能手机应用程序接受糖尿病自我管理教育,以触发糖尿病自我管理:单向短信,免费,基于证据和心理理论的饮食习惯,体育锻炼,低血糖症和葡萄糖变异性。患者选择自己喜欢的频率(每周两次至六次),主题(除低血糖症外还需另外两三个主题,这是必不可少的主题)和持续时间(6或9个月)。对照组(n = 114)将照常接受护理。主要研究终点是随访6个月后的HbA1c水平。达到HbA1c水平≤≤53?mmol / mol(≤7%)而无低血糖(血浆葡萄糖<≤3.5?mmol / L(≤63?mg / dL))的患者是共同主要结果。次要结果是体重指数,腰围,胰岛素剂量,脂质状况,血压,降血糖事件的次数,血糖变异性,自我管理(SDSCA),饮食习惯(FFQ),身体活动(IPAQ),健康状况(EQ) -5D-5?L,SF36),糖尿病相关的生活质量(ADDQoL),糖尿病治疗满意度(DTSQ),对应用程序的满意度,3个月后的干预措施的成本效益以及干预效果的可持续性(在干预组中进行了3个月的额外随访,以比较该应用的使用时间与停止使用之间的差异。我们将使用意向性处理原理来分析数据。需要创新的解决方案来提高针对越来越多的T2DM患者的自我管理的(成本)有效性。该试验将提供证据证明新开发的智能手机应用程序的有效性,该应用程序旨在引发糖尿病自我管理。荷兰审判注册簿NTR5515,注册日期:2015年11月18日(可能已注册)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号